We are monitoring the impact of COVID-19 on Varicose Vein Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2505
Share on
Share on

Global Varicose vein Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Treatment Type, Devices, End-User & Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2505
Pages: 175

Global Varicose Vein Treatment Market Size (2021 to 2026)

The size of the global varicose vein treatment market is estimated to grow USD 477.33 million by 2026 and USD 350.03 million in 2021, growing at a CAGR of 6.40% during the forecast period.

The rising cases of varicose veins mainly drive the varicose vein treatment market. This condition of enlarged veins appears mostly in the feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders, and high blood pressure.

MARKET DRIVERS:

The growth of the global varicose vein treatment market is primarily driven by the availability of advanced varicose vein treatment devices, a massive burden of varicose vein cases, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth of the aging population.

The emergence of less invasive treatment procedures coupled with the growth of the geriatric population is expected to drive the market growth during the forecast period. Furthermore, the world varicose vein treatment market is further fueled by improved patient compliance through the advent of sustainable and safe techniques to cope with the huge burden of varicose veins incidents and increased access to medical devices for varicose veins. Additionally, the healthcare industry has seen a new trend of removing or destroying superficial veins with an improved patient experience.

Companies in the varicose vein treatment market are increasing R&D to develop devices and garments with adequate compression that help reduce the incidence of pain associated with their use. According to the research article published in the Egyptian Family Medicine Journal, 2020, the prevalence of varicose veins in women was found to be 52.1% at the El-Nahda Center in the El-Salam Medical Zone in Cairo in Egypt. Hence, the increasing prevalence of varicose veins among the diverse global populations is expected to increase the market's growth. One of the many drivers of this industry is that the prevalence of varicose veins is high among women. It is more common in older women. The risk of varicose veins is higher in pregnant women and women taking hormone therapy for menopause. It is reported that women have twice the risk of varicose veins than men.

Furthermore, the growing number of super-specialty hospitals with advanced infrastructure and an increase in the number of technologically advanced treatment products to treat the patients suffering from varicose vein diseases significantly promote market growth. In addition, the easy availability of devices used for the varicose veins treatment process, acceptable reimbursement policies, and aesthetics’ growing significance propel the demand of the worldwide varicose vein treatment market. The rising occurrences of the varicose vein health condition opened many opportunities for the major companies offering a wide variety of efficient treatment options.

MARKET RESTRAINTS:

However, the shortage of trained vascular surgeons and the high cost of varicose vein treatment procedures can hinder the growth of the global varicose vein treatment market. Developing countries such as India and South Africa face some challenges while dealing with varicose veins as there are high unmet needs. The challenges associated with the inconsistent reimbursement scenario for varicose vein treatment procedures.

MARKET OPPORTUNITIES:

The condition of varicose veins is common in many people. The increasing incidence of this health problem has opened up opportunities for companies in the varicose vein treatment market to offer various effective treatment options.

Healthcare providers increasingly adopt advancements such as ultrasound-guided foam sclerotherapy in the field of varicose vein treatment. As a result, the companies are stepping up their research efforts to develop improved foam formulations, as the foam acts as a suitable alternative to the liquid. This treatment creates additional opportunities for the healthcare industry as sclerotherapy is associated with better outcomes and fewer complications in patients.

MARKET CHALLENGES:

Hygiene issues are also hindering the adoption of compression products. The biggest challenge in this industry is neovascularization, a process in which the re-growth of veins occurs. It is possible that even after surgery, varicose veins will grow back. Sometimes varicose veins can develop on other parts of the legs.

Impact of COVID-19 on the global varicose vein treatment market:

Before the COVID-19 pandemic, doctors routinely performed elective, critical, and urgent procedures to treat vascular disease. For example, removing varicose veins, removing the saphenous vein due to reflux, mechanical/thrombolytic treatment of venous thromboembolism, placement of a venous stent, and insertion or removal of the inferior vena cava filter (IVC) were common elective venous procedures.

Urgent and emerging venous thromboembolism and vascular injury cases represent approximately 30-50% of a combination of active vascular surgery cases when associated with non-selective arterial disease. Consequently, many venous pathology professionals devote most of their case volumes to outpatient treatment of venous diseases.

The coronavirus pandemic has changed this status quo, threatening the speed and productivity of care. Doctors have been faced with the possibility of exposing patients to COVID-19 by accepting them into a hospital or office. Ambulatory clinics and office laboratories providing diagnostic and treatment services have also been severely influenced. The worst impact has been on elective care for venous disease, mainly on an outpatient basis.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Treatment Type, Devices, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

This research report segmented and sub-segmented the global varicose vein treatment market into the following categories and evaluated market size and forecast for each segment until 2026.

Varicose Vein Treatment Market - By Treatment Types:

  • Surgical Treatments
    • Vein Ligation and Stripping
    • Phlebectomy
  • Non-Surgical Treatments
    • Laser Therapy
    • Trans-Illuminated Powered Phlebectomy (Trivex)
  • Radiofrequency Ablation
    • Sclerotherapy

The radiofrequency ablation devices segment is expected to command a significant share of the ablation devices market for varicose vein treatment based on the treatment type.

The sclerotherapy segment is predicted to be the fastest-growing segment in the global varicose vein treatment market during the forecast period. Factors such as requiring less bruising and scarring, simple follow-up treatments, and favorable reimbursement policies are propelling the demand of this segment.

Varicose Vein Treatment Market - By Device:

  • Ablation devices
    • Radiofrequency Ablation Devices
    • Laser Ablation Devices
  • Venous Closure Products
  • Surgical Products

By device, the radiofrequency ablation devices dominate the varicose veins treatment market. The segment holds a 41.07% market share and is an effective treatment for facet joints, avoids surgery, and immediate pain relief.

Varicose Vein Treatment Market - By End-User:

  • Surgery Centers
  • Hospitals
    • Specialty Hospitals
    • Multispecialty Hospitals

Based on the end-user, the hospital segment is projected to lead the global varicose vein treatment market during the forecast period and accounted for a market share of 54.4% in 2020. The rise in the adoption of treatment procedures and the easy availability of varicose vein treatments are majorly fuelling the market's growth rate.

Varicose Vein Treatment Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, The varicose vein treatment in North America is predicted to be dominating the global varicose vein treatment market, followed by Europe during the forecast period. The launch of technologically advanced treatments, Y-O-Y growth in varicose vein cases, and developed healthcare infrastructure are primarily driving this regional market. In North America, the United States varicose vein treatment market had accounted majority of the share and is predicted to continue its domination throughout the forecast period. With favorable reimbursement policies, the U.S. population can get treatment at a low cost. According to Chicago Vein Institute, varicose veins incidence is higher in women than in men, 55% in women and 45% in men. The Canadian varicose vein treatment market is predicted to grow at a healthy rate between 2020 to 2025. The BTG International Canada, Inc. introduced Varithena, a drug/device combination to treat varicose veins. It is used mainly for adults with clinically essential venous reflux diagnosed by duplex ultrasound.

The varicose veins treatment market in Europe is likely to have promising growth, and the market is to have a CAGR of 6.3% from 2020 to 2025. The development of this regional market is mainly driven by the factors such as improved healthcare infrastructure, growing access to varicose vein medical devices, and patient compliance. As a result, European countries such as the U.K, Germany, and France are expected to have lucrative CAGR during the forecast period, and the U.K to govern most European market share.

The varicose vein treatment market in Asia Pacific is anticipated to witness impressive growth in the near future. Rising awareness levels in the patients to have early diagnosis and treatment and rapid rise in the aging population in the APAC counties are majorly accelerating the market growth in this region.  The Chinese market is predicted to lead this regional market due to growing healthcare expenses, the surge in the high adoption of unhealthy lifestyles, and rising disposable income accelerating the market demand. On the other hand, India and Japan are expected to have impulsive market growth, with favorable government initiatives, high adoption of laser treatments, and many key players. 

The varicose vein treatment market in Latin America is another lucrative region globally and is predicted to register a notable CAGR during the forecast period. The rising patient compliance, growing geriatric population, and hike in healthcare expenditure are expected to drive this regional market. The Brazilian market is forecasted to dominate this regional market between 2020 to 2025.

The varicose vein treatment market in Middle East & Africa is anticipated to have considerable growth from 2020 to 2025. The launch of durable and reliable procedures and constant efforts in improving the healthcare infrastructure are creating growth opportunities for the market in this region. As a result, Africa is likely to have an inclined growth rate in this period.

KEY MARKET PLAYERS:

Some of the promising companies leading the global varicose vein treatment market profiled in the report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.).

RECENT MARKET HAPPENINGS:

  • March 2018: AccuVein Inc. announced the launch of the AccuVein AV400 vein viewing system. The AV400 can see veins up to 10mm deep and quickly detect large and small veins. In addition, an inverse model has been added that further helps to highlight small veins.
  • August 2017: Maury Regional Health resorted to the adoption of vein visualization as a standard for healthcare in the concerned region. The market for AccuVein is expected to grow. Maury Regional Health is one of the largest healthcare providers for Nashville, Tennessee, and Huntsville, Alabama.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Endovenous ablation          

                                5.1.3 Surgical litigation/ Stripping              

                                5.1.4 Sclerotherapy        

                                5.1.5  Y-o-Y Growth Analysis, By Treatment         

                                5.1.6  Market Attractiveness Analysis, By Treatment       

                                5.1.7  Market Share Analysis, By Treatment        

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Ablation devices   

                                                5.2.2.1 Radiofrequency ablation devices

                                                5.2.2.2. Laser ablation devices

                                5.2.3 Venous closure products  

                                5.2.4 Surgical products  

                                5.2.5 Y-o-Y Growth Analysis, By Product               

                                5.2.6 Market Attractiveness Analysis, By Product             

                                5.2.7 Market Share Analysis, By Product               

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By Product

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By Product

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By Product

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Medtronic plc                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 AngioDynamics, Inc.                               

                8.3 Syneron Medical Ltd.                             

                8.4 Lumenis Ltd.                              

                8.5 Dornier MedTech GmbH                      

                8.6 Energist Group                          

                8.7 Vascular Solutions, Inc.                          

                8.8 Merz Aesthetics         

                8.9 AccuVein Inc

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

11.Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identifying the regions that are still untapped

  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail

  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development

  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment

  • Competitive landscape analysis lists out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies

  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions

  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

  1. Global Varicose vein treatment Market, By Region, From 2021 to 2026 (USD Million)

  2. Global Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  3. Global Endovenous ablation Market, By Region, From 2021 to 2026 (USD Million)

  4. Global Surgical litigation/ Stripping Market, By Region, From 2021 to 2026 (USD Million)

  5. Global Sclerotherapy Market, By Region, From 2021 to 2026 (USD Million)

  6. Global Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  7. Global Ablation devices Market, By Region, From 2021 to 2026 (USD Million)

  8. Global Venous Closure products Market, By Region, From 2021 to 2026 (USD Million)

  9. Global Surgical products Market, By Region, From 2021 to 2026 (USD Million)

  10. North America Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  11. North America Endovenous ablation Market, By Region, From 2021 to 2026 (USD Million)

  12. North America Surgical litigation/ Stripping Market, By Region, From 2021 to 2026 (USD Million)

  13. North America Sclerotherapy Market, By Region, From 2021 to 2026 (USD Million)

  14. North America Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  15. North America Ablation devices Market, By Region, From 2021 to 2026 (USD Million)

  16. North America Venous Closure products Market, By Region, From 2021 to 2026 (USD Million)

  17. North America Surgical products Market, By Region, From 2021 to 2026 (USD Million)

  18. United States Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  19. United States Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  20. Canada Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  21. Canada Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  22. Europe Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  23. Europe Endovenous ablation Market, By Region, From 2021 to 2026 (USD Million)

  24. Europe Surgical litigation/ Stripping Market, By Region, From 2021 to 2026 (USD Million)

  25. Europe Sclerotherapy Market, By Region, From 2021 to 2026 (USD Million)

  26. Europe Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  27. Europe Ablation devices Market, By Region, From 2021 to 2026 (USD Million)

  28. Europe Venous Closure products Market, By Region, From 2021 to 2026 (USD Million)

  29. Europe Surgical products Market, By Region, From 2021 to 2026 (USD Million)

  30. U.K. Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  31. U.K. Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  32. Germany Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  33. Germany Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  34. France Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  35. France Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  36. Italy Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  37. Italy Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  38. Spain Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  39. Spain Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  40. Asia-Pacific Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  41. Asia-Pacific Endovenous ablation Market, By Region, From 2021 to 2026 (USD Million)

  42. Asia-Pacific Surgical litigation/ Stripping Market, By Region, From 2021 to 2026 (USD Million)

  43. Asia-Pacific Sclerotherapy Market, By Region, From 2021 to 2026 (USD Million)

  44. Asia-Pacific Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  45. Asia-Pacific Ablation devices Market, By Region, From 2021 to 2026 (USD Million)

  46. Asia-Pacific Venous Closure products Market, By Region, From 2021 to 2026 (USD Million)

  47. Asia-Pacific Surgical products Market, By Region, From 2021 to 2026 (USD Million)

  48. Japan Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  49. Japan Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  50. China Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  51. China Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  52. India Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  53. India Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  54. Australia Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  55. Australia Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  56. South Korea Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  57. South Korea Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  58. Latin America Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  59. Latin America Endovenous ablation Market, By Region, From 2021 to 2026 (USD Million)

  60. Latin America Surgical litigation/ Stripping Market, By Region, From 2021 to 2026 (USD Million)

  61. Latin America Sclerotherapy Market, By Region, From 2021 to 2026 (USD Million)

  62. Latin America Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  63. Latin America Ablation devices Market, By Region, From 2021 to 2026 (USD Million)

  64. Latin America Venous Closure products Market, By Region, From 2021 to 2026 (USD Million)

  65. Latin America Surgical products Market, By Region, From 2021 to 2026 (USD Million)

  66. Brazil Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  67. Brazil Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  68. Argentina Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  69. Argentina Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  70. Mexico Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  71. Mexico Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  72. Rest of Latin America Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  73. Rest of Latin America Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  74. Middle East & Africa Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  75. Middle East & Africa Endovenous ablation Market, By Region, From 2021 to 2026 (USD Million)

  76. Middle East & Africa Surgical litigation/ Stripping Market, By Region, From 2021 to 2026 (USD Million)

  77. Middle East & Africa Sclerotherapy Market, By Region, From 2021 to 2026 (USD Million)

  78. Middle East & Africa Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  79. Middle East & Africa Ablation devices Market, By Region, From 2021 to 2026 (USD Million)

  80. Middle East & Africa Venous Closure products Market, By Region, From 2021 to 2026 (USD Million)

  81. Middle East & Africa Surgical products Market, By Region, From 2021 to 2026 (USD Million)

  82. Middle East Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  83. Middle East Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  84. Africa Varicose vein treatment Market, By Treatment, From 2021 to 2026 (USD Million)

  85. Africa Varicose vein treatment Market, By Product, From 2021 to 2026 (USD Million)

  86. Global Varicose vein treatment Market, By Ablation devices, From 2021 to 2026 (USD Million)

  87. Global Radiofrequency Ablation Devices Market, By Region, From 2021 to 2026 (USD Million)

  88. Global Laser Ablation Devices Market, By Region, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample